Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Dermatitis Artefacta Treatment
9
Mins
June 2024
Dermatitis artefacta (DA), also known as artefactual skin disease, is a rare psychocutaneous disorder characterised by…
Read more
5
Mins
28th October 2019
Pathways to Silencing Psoriasis: Remission or Cure?
Psoriasis occurs more frequently alongside other IMID, indicating common pathogenetic pathways. Many of these IMID show familial accumulation…
4
Mins
18th October 2019
Advances and Latest Insights in Non-Biologic Systemic Therapeutic Agents in Psoriasis and Atopic Dermatitis
The fumarates, monoethyl fumarate (MEF) and dimethyl fumarate (DMF), are potent ester derivatives of fumaric acid. Fumaric acid esters (FAE)…
10
Mins
17th September 2019
IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance
This sponsored symposium took place on 12th June 2019 in Milan, Italy, as part of the 24th World Congress of Dermatology (WCD), 2019
9
Mins
16th September 2019
Spotlight on Acne
This symposium took place on 13th June 2019, as part of the World Congress of Dermatology (WCD) symposium in Milan, Italy
4
Mins
12th September 2019
Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review
Sarcoidosis is a multisystem disease, of unknown aetiology, which can involve any organ of the body, even if it more frequently affects the lymph nodes…
9
Mins
11th September 2019
IL-23 Inhibition as a Key Component in Psoriasis Treatment is Here to Stay
Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.
10
Mins
20th August 2019
Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference
Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
10
Mins
13th June 2019
Chemokine Pathway Can Be the Potential Therapeutic Target for Hypertrophic Scar
Hypertrophic scar (HTS) is a dermal form of fibroproliferative disease that develops after deep burns, skin injuries, and surgical wounds. HTS is defined…
Loading posts...
« Previous
1
…
11
12
13
14
15
…
25
Next »